Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: present situation and future prospects.

F Gros1

  • 1Institut Pasteur (URA-CNRS 1148), Unité de Biochimie, Paris, France.

Neuromuscular Disorders : NMD
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses.

Cell death and differentiation·2015
Same author

[Impact of socioeconomic status on stage at diagnosis of breast cancer].

Revue d'epidemiologie et de sante publique·2011
Same author

Regulation of neuron-specific enolase isozyme levels during differentiation of murine neuroblastoma cell cultures.

Neurochemistry international·2010
Same author

Simultaneous evaluation of mRNAs of dopamine ?-hydroxylase, tyrosine hydroxylase and proenkephalin a from three human pheochromocytomas.

Neurochemistry international·2010
Same author

Transition between isozymic forms of enolase during in vitro differentiation of neuroblastoma cells-II.

Neurochemistry international·2010
Same author

Action of penicillin on the carbohydrate metabolism of Clostridium sporogenes.

Comptes rendus hebdomadaires des seances de l'Academie des sciences·2010
Same journal

Aquatic training improves muscle strength and functional mobility in adults with myotonic dystrophy type 1: a pilot randomized trial.

Neuromuscular disorders : NMD·2026
Same journal

Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.

Neuromuscular disorders : NMD·2026
Same journal

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same journal

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Neuromuscular disorders : NMD·2026
Same journal

Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.

Neuromuscular disorders : NMD·2026
Same journal

HACD1-related congenital myopathy skeletal muscle MRI findings in a Brazilian cohort.

Neuromuscular disorders : NMD·2026
See all related articles

Gene therapy offers promising treatments for severe genetic disorders using viral vectors or direct DNA injection. This approach enables gene correction in cells and tissues, with recent human trials indicating significant therapeutic potential.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Severe monogenic diseases pose significant therapeutic challenges.
  • Traditional treatments often manage symptoms rather than addressing the genetic root cause.

Purpose of the Study:

  • To review experimental approaches for therapeutic gene treatment of severe monogenic diseases.
  • To assess the efficacy of gene transfer techniques in correcting genetic defects.

Main Methods:

  • Survey of in vitro cultivated cell systems and animal models for gene therapy research.
  • Evaluation of viral-mediated gene transfer and direct DNA injection techniques.
  • Analysis of gene insertion into chromosomes or episomal activity.

Main Results:

Related Experiment Videos

  • Successful long-term expression of introduced genetic information achieved in many cases.
  • Compensation or correction of genetic defects demonstrated in cultivated cells and in vivo.
  • Advancements in gene transfer techniques enabling stable gene insertion or episomal activity.

Conclusions:

  • Somatic gene therapy represents a significant new strategy for treating genetic diseases.
  • Recent approvals for human trials highlight the growing clinical acceptance and importance of gene therapy.
  • Ethical considerations associated with gene therapy require careful discussion and management.